Our Partners
The Osteoarthritis Research Society International (OARSI) is the official partner of the 3rd International Workshop in Epigenetics on Osteoarthritis. It is the leading medical society for advancing the understanding, early detection, treatment and prevention of osteoarthritis through its exclusive dedication to research. With more than 30 years of experience, OARSI provides the necessary framework, expert resources and support for its international constituents to address the challenges of osteoarthritis so that the knowledge gained can ultimately be used to help improve patient care and patient outcomes.
To learn more, please click here.
The Schroeder Arthritis Institute is the largest multidisciplinary arthritis hub in Canada, integrating medical, surgical and basic science aspects of Hand, Orthopedics, Osteoporosis and Rheumatology with a goal of making a global impact in discovery, learning and patient care.
To learn more, please click here.
The Canadian Institutes for Health Research Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) is the official partner for the 3rd International Workshop on the Epigenetics of Osteoarthritis. IMHA is one of thirteen virtual institutes of CIHR, and is the hub for strategic initiatives in musculoskeletal (MSK), skin and oral health research in Canada. IMHA is mandated to provide research leadership related to: active living, mobility and the wide range of conditions related to bones, joints, muscles, connective tissue, skin as well as the mouth, teeth and craniofacial region. Within this mandate, the IMHA community consists of researchers, policy-makers, clinicians, health charities, patient organizations and people with lived experience. IMHA aims to provide research leadership and to authentically engage a broad community including those who have historically been excluded from participating in research.
To learn more, please click here.
The Schroeder Arthritis Institute is the largest multidisciplinary arthritis hub in Canada, integrating medical, surgical and basic science aspects of Hand, Orthopedics, Osteoporosis and Rheumatology with a goal of making a global impact in discovery, learning and patient care.
To learn more, please click here.
Arthritis Society Canada is the official partner for the 3rd International Workshop on the Epigenetic of Osteoarthritis. Arthritis Society Canada is the leading national charity dedicated to extinguishing arthritis. Fueled by the trust and support of their donors and volunteers, Arthritis Society Canada is fighting the fire of arthritis with research, advocacy, innovation, information and support. They are Canada's largest charitable funder of cutting-edge arthritis research. To learn more, please click here.
To learn more, please click here.
Versus Arthritis is the official partner for the 3rd International Workshop on the Epigenetics of Osteoarthritis. We are Versus Arthritis. We’re the 10 million people living with arthritis. We’re the carers, researchers, healthcare professionals, friends, parents, runners and fundraisers all united in our ambition to ensure that one day, no one will have to live with the pain, fatigue and isolation that arthritis causes. There are over 10 million people living with arthritis. That’s one in six, with over half of those living in pain every single day. The impact is huge as the condition slowly intrudes on everyday life – affecting the ability to work, care for a family, to move free from pain and to live independently. Yet arthritis is often dismissed as an inevitable part of ageing or shrugged off as ‘just a bit of arthritis’. We don’t think that this is OK. Versus Arthritis is here to change that.
Versus Arthritis is the UK's largest charity dedicated to supporting people with arthritis. It was launched in September 2018, following the legal merger of the two leading arthritis charities in the UK, Arthritis Research UK and Arthritis Care in November 2017.
To learn more, please click here.
ReumaNederland is the official partner for the 3rd International Workshop on the Epigenetics of Osteoarthritis. More than two million people in the Netherlands suffer from rheumatic diseases, most commonly from osteoarthritis. Patients, doctors, researchers, politicians, caregivers, and industry – ReumaNederland team has the same goal: better quality of life with rheuma. To that end, ReumaNederland connects, supports financially, gives direction, and requests attention.
To learn more, please click here.
Arthritis Society Canada is the official partner for the 3rd International Workshop on the Epigenetic of Osteoarthritis. Arthritis Society Canada is the leading national charity dedicated to extinguishing arthritis. Fueled by the trust and support of their donors and volunteers, Arthritis Society Canada is fighting the fire of arthritis with research, advocacy, innovation, information and support. They are Canada's largest charitable funder of cutting-edge arthritis research. To learn more, please click here.
To learn more, please click here.
Association Française de Lutte Anti-Rhumatismale (AFLAR) is the official partner for the 3rd International Workshop on the Epigenetics of Osteoarthritis. AFLAR was founded in 1928 and recognized public utility since 1937. It is the French patient's association against rheumatism and musculoskeletal diseases.
AFLAR optimizes and coordinates the fight against rheumatism in all its aspects such as Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Spondyloarthopathy, Psoriatic Arthritis, SAPHO, Gout, chronic low back pain, musculoskeletal disorders and more.
To learn more, please click here.
Our Corporate Sponsor
chiron is the official partner for the 3rd International Workshop on the Epigenetics of Osteoarthritis. Located in the Netherlands, chiron is a company developing leading on-chip biotechnologies with a particular focus on platforms that apply physiological biomechanical strains to 3D cultures. The novel technology is ideally suited for musculoskeletal organ-chip models, such as cartilage, which is where the company specializes—recapitulating tissues within the joints and tackling diseases like osteoarthritis and rheumatoid arthritis. chiron collaborates openly with academics and research institutes and provides customer-service focused research services to the pharmaceutical industry.
To learn more, please click here.